Harald H.H.W. Schmidt

Harald H.H.W. Schmidt

Universiteit Maastricht

H-index: 102

Europe-Netherlands

About Harald H.H.W. Schmidt

Harald H.H.W. Schmidt, With an exceptional h-index of 102 and a recent h-index of 51 (since 2020), a distinguished researcher at Universiteit Maastricht, specializes in the field of Systems Medicine, Network Pharmacology, Drug Repurposing.

His recent articles reflect a diverse array of research interests and contributions to the field:

Drug Repurposing: The End of Medicines As We Knew Them

On a revised pharmacology of apo-soluble guanylate cyclase and its therapeutic implications

The concise guide to PHARMACOLOGY 2023/24: catalytic receptors

Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes

Receptor guanylyl cyclase (RGC) family in GtoPdb v. 2023.1

The FeatureCloud platform for federated learning in biomedicine: unified approach

Understanding (apo-) soluble guanylate cyclase allosterism and its therapeutic implications

From Genomic Puzzles to Network Solutions: Charting Parkinson’s Path using Systematic Review/Meta Analysis as the Compass

Harald H.H.W. Schmidt Information

University

Universiteit Maastricht

Position

Professor & Chair of Pharmacology and Personalised Medicine

Citations(all)

38965

Citations(since 2020)

9319

Cited By

32787

hIndex(all)

102

hIndex(since 2020)

51

i10Index(all)

234

i10Index(since 2020)

137

Email

University Profile Page

Universiteit Maastricht

Harald H.H.W. Schmidt Skills & Research Interests

Systems Medicine

Network Pharmacology

Drug Repurposing

Top articles of Harald H.H.W. Schmidt

Title

Journal

Author(s)

Publication Date

Drug Repurposing: The End of Medicines As We Knew Them

RExPO22 Conference

Harald HHW Schmidt

2023/10/13

On a revised pharmacology of apo-soluble guanylate cyclase and its therapeutic implications

DrugRxiv

Alexandra Petraina

Mahmoud H Elbatreek

Christopher T Neullens

Theodora Saridaki

Vu Thao-Vi Dao

...

2023/1/30

The concise guide to PHARMACOLOGY 2023/24: catalytic receptors

British Journal of Pharmacology

Stephen PH Alexander

Doriano Fabbro

Eamonn Kelly

Alistair A Mathie

John A Peters

...

2023/10

Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes

Journal of Alzheimer's Disease

Mayra Pacheco Pachado

Ana I Casas

Mahmoud H Elbatreek

Cristian Nogales

Emre Guney

...

2023

Receptor guanylyl cyclase (RGC) family in GtoPdb v. 2023.1

IUPHAR/BPS Guide to Pharmacology CITE

Annie Beuve

Peter Brouckaert

John C Burnett Jr

Andreas Friebe

John Garthwaite

...

2023/4/26

The FeatureCloud platform for federated learning in biomedicine: unified approach

Journal of Medical Internet Research

Julian Matschinske

Julian Späth

Mohammad Bakhtiari

Niklas Probul

Mohammad Mahdi Kazemi Majdabadi

...

2023

Understanding (apo-) soluble guanylate cyclase allosterism and its therapeutic implications

DrugRxiv

Alexandra Petraina

Mahmoud H Elbatreek

Christopher T Neullens

Theodora Saridaki

Vu Thao-Vi Dao

...

2023/4/11

From Genomic Puzzles to Network Solutions: Charting Parkinson’s Path using Systematic Review/Meta Analysis as the Compass

Zina Piper

Zeinab M Maamdouh

Mayra Pacheco Pachado

Rick A Reijnders

Ehsan Pishva

...

2023/10/17

Why the way we define diseases prevents innovation and precision medicine

Zeinab Mohamed Mamdouh Abdelkareem Gomaa

E Anastasi

Ahmed Hassan

Johannes Boltze

Mahmoud Elbatreek

...

2023/2/1

Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology

Alexandra Petraina

Cristian Nogales

Thomas Krahn

Hermann Mucke

Thomas F Lüscher

...

2022/6/1

Network pharmacology drug repurposing strategy for neurovascular diseases

Ana I Casas

Cristian Nogales

Mahmoud H Elbatreek

Sepideh Sadegh

Elisa Anastasi

...

2022/7/25

Repurposing soluble guanylate cyclase stimulators from one to another isoform within the ROCG signalling module

Alexandra Petraina

Mahmoud H Elbatreek

Christin Elgert

Ana I Casas

Christopher T Neullens

...

2022/8/29

Privacy-preserving artificial intelligence techniques in biomedicine

Methods of information in medicine

Reihaneh Torkzadehmahani

Reza Nasirigerdeh

David B Blumenthal

Tim Kacprowski

Markus List

...

2022/6

Un-biased housekeeping gene panel selection for high-validity gene expression analysis

Scientific Reports

Ana I Casas

Ahmed A Hassan

Quirin Manz

Christian Wiwie

Pamela Kleikers

...

2022/7/19

An organ-agnostic drug repurposing strategy for dementia: Pre-clinical validation of network pharmacology to treat cerebrovascular dysfunction and cognitive impairment

Mayra Pacheco Pachado

Alexandra Petraina

Cristian Nogales

Theodora Saridaki

Harald HHW Schmidt

...

2022/8/29

Re-discover the Whole Patient

Harald HHW Schmidt

2022/5/4

Endothelial reactive oxygen-forming NADPH oxidase 5 is a possible player in diabetic aortic aneurysm but not atherosclerosis

Scientific Reports

Florence Ho

Anna MD Watson

Mahmoud H Elbatreek

Pamela WM Kleikers

Waheed Khan

...

2022/7/7

Network pharmacology and drug repurposing pave the way for precision oncology

Zeinab M Mamdouh

Cristian Nogales

Cecili Macchiusi

Mahmoud H Elbatreek

Mayra Pacheco Pachado

...

2022/8/29

Implication of type 4 NADPH oxidase (NOX4) in tauopathy

Redox Biology

Enrique Luengo

Paula Trigo-Alonso

Cristina Fernández-Mendívil

Ángel Nuñez

Marta Del Campo

...

2022/2/1

Cancer driver drug interaction explorer

Nucleic Acids Research

Michael Hartung

Elisa Anastasi

Zeinab M Mamdouh

Cristian Nogales

Harald HHW Schmidt

...

2022/7/5

See List of Professors in Harald H.H.W. Schmidt University(Universiteit Maastricht)

Harald H.H.W. Schmidt FAQs

What is Harald H.H.W. Schmidt's h-index at Universiteit Maastricht?

The h-index of Harald H.H.W. Schmidt has been 51 since 2020 and 102 in total.

What are Harald H.H.W. Schmidt's top articles?

The articles with the titles of

Drug Repurposing: The End of Medicines As We Knew Them

On a revised pharmacology of apo-soluble guanylate cyclase and its therapeutic implications

The concise guide to PHARMACOLOGY 2023/24: catalytic receptors

Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes

Receptor guanylyl cyclase (RGC) family in GtoPdb v. 2023.1

The FeatureCloud platform for federated learning in biomedicine: unified approach

Understanding (apo-) soluble guanylate cyclase allosterism and its therapeutic implications

From Genomic Puzzles to Network Solutions: Charting Parkinson’s Path using Systematic Review/Meta Analysis as the Compass

...

are the top articles of Harald H.H.W. Schmidt at Universiteit Maastricht.

What are Harald H.H.W. Schmidt's research interests?

The research interests of Harald H.H.W. Schmidt are: Systems Medicine, Network Pharmacology, Drug Repurposing

What is Harald H.H.W. Schmidt's total number of citations?

Harald H.H.W. Schmidt has 38,965 citations in total.

What are the co-authors of Harald H.H.W. Schmidt?

The co-authors of Harald H.H.W. Schmidt are Mark Cooper, Rhian Touyz, Hossein Ardeschir Ghofrani, Kathy Griendling, Jane A Mitchell.

Co-Authors

H-index: 175
Mark Cooper

Mark Cooper

Monash University

H-index: 143
Rhian Touyz

Rhian Touyz

University of Glasgow

H-index: 117
Hossein Ardeschir Ghofrani

Hossein Ardeschir Ghofrani

Justus-Liebig-Universität Giessen

H-index: 114
Kathy Griendling

Kathy Griendling

Emory University

H-index: 90
Jane A Mitchell

Jane A Mitchell

Imperial College London

academic-engine